Weinstock, Tanya G.
Vertex Pharmaceuticals (United States)
3 papers on CoChatORCID 0009-0009-8448-7453
Most cited papers
- Verified
A Controlled Trial of CPAP Therapy on Metabolic Control in Individuals with Impaired Glucose Tolerance and Sleep Apnea
Weinstock, T. G., Wang, X., Rueschman, M., Ismail-Beigi, F., Aylor, J., Babineau, D. C., Mehra, R., & Redline, S. (2012) · Sleep
Obstructive Sleep Apnea ResearchSleep and related disorders
Cited by 181
- Verified
Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study
Bower, J. K., Volkova, N., Ahluwalia, N., Sahota, G., Xuan, F., Chin, A., Weinstock, T. G., Ostrenga, J., & Elbert, A. (2023) · Journal of Cystic Fibrosis
Cystic Fibrosis Research AdvancesPharmacogenetics and Drug Metabolism
Cited by 140
- Verified
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study
Daines, C. L., Tullis, E., Costa, S., Linnemann, R. W., Mall, M. A., McKone, E. F., Polineni, D., Quon, B. S., Ringshausen, F. C., Rowe, S. M., et al. (2023) · European Respiratory Journal
Cystic Fibrosis Research AdvancesPharmacogenetics and Drug Metabolism
Cited by 100
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free